HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Kawamura Selected Research

Takeshi Kawamura Research Topics

Disease

16Neoplasms (Cancer)
12/2024 - 07/2010
11COVID-19
05/2024 - 03/2021
8Inflammation (Inflammations)
01/2019 - 01/2002
4Infections
11/2023 - 10/2002
4Leukemia
01/2021 - 04/2014
4Lung Neoplasms (Lung Cancer)
12/2015 - 04/2010
3Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2023 - 01/2005
3Proteinuria
07/2010 - 01/2005
2Fever (Fevers)
01/2023 - 01/2022
2Chronic Kidney Failure (Chronic Renal Failure)
01/2023 - 02/2009
2Arthralgia (Joint Pain)
01/2023 - 01/2022
2Carcinoma (Carcinomatosis)
01/2022 - 01/2021
2Wilms Tumor (Wilm's Tumor)
11/2021 - 11/2013
2Thrombosis (Thrombus)
03/2020 - 06/2016
2Neutropenia
01/2020 - 01/2019
2Diabetic Nephropathies (Diabetic Nephropathy)
06/2019 - 07/2018
2Hypertension (High Blood Pressure)
06/2019 - 07/2018
2Body Weight (Weight, Body)
06/2019 - 05/2015
2Diabetes Mellitus
06/2019 - 07/2018
2Liver Failure
01/2019 - 04/2012
2Adenocarcinoma of Lung
12/2015 - 04/2010
2Liposarcoma
08/2011 - 01/2011
2Ascites
08/2011 - 10/2010
1Renal Cell Carcinoma (Grawitz Tumor)
12/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2024
1Communicable Diseases (Infectious Diseases)
05/2024
1Hypophosphatemia
01/2023
1Chronic Disease (Chronic Diseases)
01/2023
1Headache (Headaches)
01/2023
1Diarrhea
01/2023
1Genomic Instability
11/2022
1Virus Diseases (Viral Diseases)
06/2021
1Hypoxia (Hypoxemia)
01/2021
1Type 2 von Willebrand Disease
03/2020
1Immunoglobulin G4-Related Disease
10/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2007
8Immunoglobulin G (IgG)IBA
01/2023 - 10/2019
5Immunoglobulin M (IgM)IBA
05/2022 - 01/2005
4Messenger RNA (mRNA)IBA
11/2023 - 02/2010
4AntibodiesIBA
11/2023 - 01/2019
4Neutralizing AntibodiesIBA
11/2023 - 01/2016
3VaccinesIBA
05/2024 - 03/2022
3BNT162 VaccineIBA
01/2023 - 11/2022
3Rituximab (Mabthera)FDA Link
01/2019 - 12/2006
3EnzymesIBA
08/2007 - 01/2002
2Peptides (Polypeptides)IBA
12/2024 - 12/2015
2AntigensIBA
11/2023 - 01/2019
2silicon phthalocyanineIBA
12/2022 - 01/2022
2Immunoglobulin A (IgA)IBA
05/2022 - 02/2022
2Viral ProteinsIBA
02/2022 - 06/2021
2LigandsIBA
01/2016 - 06/2012
2ParaffinIBA
12/2015 - 04/2010
2Formaldehyde (Formol)FDA Link
12/2015 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
08/2011 - 10/2010
1NucleotidesIBA
12/2024
1Cancer VaccinesIBA
12/2024
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2024
1Biotin (Vitamin H)FDA Link
02/2024
1StreptavidinIBA
02/2024
1mRNA VaccinesIBA
11/2023
12019-nCoV Vaccine mRNA-1273IBA
01/2023
1Phosphorus (Red Phosphorus)IBA
01/2023
1Cys-ZHER2-342 affibodyIBA
12/2022
1DNA (Deoxyribonucleic Acid)IBA
11/2022
1NucleoproteinsIBA
05/2022
1Nucleocapsid ProteinsIBA
02/2022
1human ERBB2 proteinIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1AntipyreticsIBA
01/2022
1iminobiotinIBA
01/2022
1IntegrinsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
11/2021
16-methyladenineIBA
11/2021
1N-methyladenosineIBA
11/2021
1MethyltransferasesIBA
06/2021
1ChromatinIBA
06/2021
1CohesinsIBA
06/2021
1OligonucleotidesIBA
05/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2021
1A-Form DNA (A-DNA)IBA
05/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1pembrolizumabIBA
01/2021
1Oncogene Proteins (Oncogene Protein)IBA
01/2021
1Translationally-Controlled 1 Tumor ProteinIBA
01/2021
1Thromboplastin (Tissue Factor)IBA
03/2020
1von Willebrand FactorIBA
03/2020
1CollagenIBA
03/2020
1Factor VIII (Coagulation Factor VIII)IBA
03/2020
1FibrinIBA
03/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Uric Acid (Urate)IBA
06/2019

Therapy/Procedure

9Kidney Transplantation
01/2023 - 01/2003
9Transplantation
01/2023 - 01/2005
8Therapeutics
02/2024 - 01/2003
4Lasers (Laser)
12/2015 - 08/2007
3Drug Therapy (Chemotherapy)
01/2011 - 03/2002
2Immunotherapy
12/2024 - 01/2021
2Hepatectomy
01/2019 - 04/2012
2Precision Medicine
01/2019 - 08/2007